Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms

被引:59
作者
Kohtala, Samuel [1 ,2 ,3 ]
机构
[1] Univ Helsinki, Div Pharmacol & Pharmacotherapy, Drug Res Program, Lab Neurotherapeut,Fac Pharm, POB 56, Helsinki 00014, Finland
[2] Univ Helsinki, SleepWell Res Program, Fac Med, Helsinki, Finland
[3] Weill Cornell Med, Dept Psychiat, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA
关键词
Ketamine; Subanesthetic; Rapid-acting antidepressant; Depression; Dose; Anesthesia; TREATMENT-RESISTANT DEPRESSION; POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; D-ASPARTATE ANTAGONIST; PHANTOM LIMB PAIN; DOUBLE-BLIND; INTRAVENOUS KETAMINE; SUBANESTHETIC KETAMINE; ORAL ANTIDEPRESSANT; DOSE KETAMINE;
D O I
10.1007/s43440-021-00232-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Over the past 50 years, ketamine has solidified its position in both human and veterinary medicine as an important anesthetic with many uses. More recently, ketamine has been studied and used for several new indications, ranging from chronic pain to drug addiction and post-traumatic stress disorder. The discovery of the rapid-acting antidepressant effects of ketamine has resulted in a surge of interest towards understanding the precise mechanisms driving its effects. Indeed, ketamine may have had the largest impact for advancements in the research and treatment of psychiatric disorders in the past few decades. While intense research efforts have been aimed towards uncovering the molecular targets underlying ketamine's effects in treating depression, the underlying neurobiological mechanisms remain elusive. These efforts are made more difficult by ketamine's complex dose-dependent effects on molecular mechanisms, multiple pharmacologically active metabolites, and a mechanism of action associated with the facilitation of synaptic plasticity. This review aims to provide a brief overview of the different uses of ketamine, with an emphasis on examining ketamine's rapid antidepressant effects spanning molecular, cellular, and network levels. Another focus of the review is to offer a perspective on studies related to the different doses of ketamine used in antidepressant research. Finally, the review discusses some of the latest hypotheses concerning ketamine's action.
引用
收藏
页码:323 / 345
页数:23
相关论文
共 50 条
  • [41] Effects of Isoliquiritigenin on Cognitive Function after Ketamine Anesthesia in Elderly Rats and the Mechanisms
    Deng, Chengqi
    Guo, Kaikai
    Zhao, Hongwei
    Xu, Yuanyuan
    Wang, Chuanqing
    Xiu, Yingying
    Pang, Liwei
    LATIN AMERICAN JOURNAL OF PHARMACY, 2020, 39 (01): : 196 - 202
  • [42] A Key Requirement for Synaptic Reelin Signaling in Rapid Antidepressant Effects of Ketamine
    Kim, Ji-Woon
    Herz, Joachim
    Kavalali, Ege
    Monteggia, Lisa
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (SUPPL 1) : 113 - 113
  • [43] Antidepressant actions of ketamine: from molecular mechanisms to clinical practice
    Monteggia, Lisa M.
    Zarate, Carlos, Jr.
    CURRENT OPINION IN NEUROBIOLOGY, 2015, 30 : 139 - 143
  • [44] R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
    Yang, C.
    Shirayama, Y.
    Zhang, J-c
    Ren, Q.
    Yao, W.
    Ma, M.
    Dong, C.
    Hashimoto, K.
    TRANSLATIONAL PSYCHIATRY, 2015, 5 : e632 - e632
  • [45] Serotonergic transmission plays differentiated roles in the rapid and sustained antidepressant-like effects of ketamine
    Yin, Yong-Yu
    Yan, Jiao-Zhao
    Wei, Qian-Qian
    Sun, Si-Rui
    Ding, Yu-Qiang
    Zhang, Li-Ming
    Li, Yun-Feng
    BRITISH JOURNAL OF PHARMACOLOGY, 2024, 181 (23) : 4874 - 4889
  • [46] Ketamine induces rapid antidepressant effects via the autophagy-NLRP3 inflammasome pathway
    Lyu, Dongbin
    Wang, Fan
    Zhang, Mengke
    Yang, Weichieh
    Huang, Haijing
    Huang, Qinte
    Wu, Chenglin
    Qian, Nuoshi
    Wang, Meiti
    Zhang, Huanfei
    Zheng, Sichai
    Chen, Jing
    Fu, Yingmei
    Zhang, Chen
    Li, Zezhi
    Hong, Wu
    PSYCHOPHARMACOLOGY, 2022, 239 (10) : 3201 - 3212
  • [47] Ketamine as a Rapid Treatment for Chronic PTSD: Clinical Effects and Potential Biological Mechanisms
    Feder, Adriana
    Murrough, James W.
    Charney, Dennis S.
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09)
  • [48] GSK-3: A key regulatory target for ketamine's rapid antidepressant effects mediated by enhanced AMPA to NMDA throughput
    Zarate, Carlos A., Jr.
    Machado-Vieira, Rodrigo
    BIPOLAR DISORDERS, 2016, 18 (08) : 702 - 705
  • [49] The Impact of Intravenous Ketamine on Attentional Bias: Probing Mechanisms of Rapid-Acting Antidepressant Effects in Two Clinical Studies
    Woody, Mary L.
    Rohac, Rebecca
    Cooper, Iya
    Griffo, Angela
    McDonald, Nastasia
    Spotts, Crystal
    Fournier, Jay
    Jones, Neil
    Pecina, Marta
    Young, Kymberly
    Shivanekar, Sharvari
    Rengasamy, Manivel
    Grafton, Ben
    Price, Rebecca B.
    BIOLOGICAL PSYCHIATRY, 2025, 97 (08) : 835 - 842
  • [50] Neurobiological mechanisms for the antidepressant effects of mind-body and physical exercises: A systematic review
    Sun, Wen
    Lu, Erin Yiqing
    Wang, Cong
    Tsang, Hector Wing Hong
    MENTAL HEALTH AND PHYSICAL ACTIVITY, 2023, 25